Latest News
Feature
Business case for interoperability remains elusive
Dr. Robert Bart sees efforts to bring ownership of health data to the individual and a clearer definition of health IT standards as important...
Literature Review
Early infusion of mononuclear cells may benefit stroke patients
Well-designed RCTs are needed to further assess safety and efficacy of the approach.
Latest News
Gastrostomy tube placement associated with higher pneumonia recurrence in children with neurologic impairment
Dental care was the only prevention strategy of eight examined that was linked to decreased recurrence.
From the Journals
Most practices not screening for five social needs
The majority of the overall screening activity was driven by interpersonal violence screenings.
From the Journals
‘Fast MRI’ may be option in TBI screening for children
Technique avoids sedation and could be an alternative to CTs, which pose radiation risk.
From the Journals
Drug abuse–linked infective endocarditis spiking in U.S.
New cases doubled from 2002 to 2016, and those affected tended to be younger white males living in poverty.
Conference Coverage
Even with no disease activity, recurrence risk near 50% when stopping DMTs for MS
STOCKHOLM – Younger patients had a significantly higher risk of recurrence when stopping disease modifying therapy.
Conference Coverage
Plasma exchange in natalizumab-related PML shows no benefit, possible harm
STOCKHOLM – Biggest-ever study of natalizumab-associated PML in patients with multiple sclerosis raises red flag regarding common practice of...
Latest News
Postdural puncture headache linked to increased risk of subdural hematoma
The subdural hematoma rate increased slightly, but significantly, to 147 per 100,000 deliveries.
Conference Coverage
Ofatumumab has superior efficacy in relapsing-remitting MS, compared with teriflunomide
STOCKHOLM – The monoclonal antibody reduced annualized relapse rate and the risk of confirmed disability worsening,...
Conference Coverage
Newer drugs provide superior disease activity control in pediatric MS
STOCKHOLM – Study from U.S. Network of Pediatric MS Centers supports early use of newer disease-modifying therapies.